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Abstract
Utero-placental growth and vascular development are critical for pregnancy establishment that 
may be altered by various factors including assisted reproductive technologies (ART), nutrition, or 
others, leading to compromised pregnancy. We hypothesized that placental vascularization and 
expression of angiogenic factors are altered early in pregnancies after transfer of embryos created 
using selected ART methods. Pregnancies were achieved through natural mating (NAT), or 
transfer of embryos from natural mating (NAT-ET), or in vitro fertilization (IVF) or activation 
(IVA). Placental tissues were collected on day 22 of pregnancy. In maternal caruncles (CAR), 
vascular cell proliferation was less (P<0.05) for IVA than other groups. Compared to NAT, 
density of blood vessels was less (P<0.05) for IVF and IVA in fetal membranes (FM), and for 
NAT-ET, IVF and IVA in CAR. In FM, mRNA expression was decreased (P<0.01–0.08) in NAT-
ET, IVF and IVA compared to NAT for vascular endothelial growth factor (VEGF) and its 
receptor FLT-1, placental growth factor (PGF), neuropilin (NP) 1 and 2, angiopoietin (ANGPT) 1 
and 2, endothelial nitric oxide synthase (NOS3), hypoxia inducible factor-1A (HIF1A), fibroblast 
growth factor (FGF) 2 and its receptor FGFR2. In CAR, mRNA expression was decreased 
(P<0.01–0.05) in NAT-ET, IVF and IVA compared to NAT for VEGF, FLT-1, PGF, ANGPT1 
and TEK. Decreased mRNA expression for 12 of 14 angiogenic factors across FM and CAR in 
NAT-ET, IVF and IVA pregnancies was associated with reduced placental vascular development, 
which would lead to poor placental function and compromised fetal and placental growth and 
development.
Introduction
Placental vascularization is initiated and established early in pregnancy and supports early 
embryonic survival and subsequent fetal growth and development (Grazul-Bilska et al. 
2010, 2011, 2013). Thus, the importance of placental vascular development during early 
pregnancy has long been recognized (Reynolds et al. 2010, 2013). During early pregnancy, 
extensive angiogenesis in maternal and fetal placental tissues progresses, accompanied by a 
marked increase in uterine and umbilical blood flows (Greiss & Anderson 1970, Reynolds 
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1986, Reynolds & Redmer 1995). Placental angiogenesis is tightly regulated by numerous 
growth and angiogenic factors (Mayhew et al. 2003, 2004a,b, Redmer et al. 2004, Grazul-
Bilska et al. 2010, 2011, Reynolds et al. 2010, 2013).
The pattern of placental vascularization and expression of factors that influence 
angiogenesis during early pregnancy after natural breeding has been established for sheep 
(Grazul-Bilska et al. 2010, 2011). However, very limited data concerning placental 
vascularization in pregnancies established after transfer of embryos obtained through 
assisted reproductive technologies (ART) or pregnancies affected by environmental factors 
during early stages of development are available. For later stages of pregnancy, it has been 
demonstrated that such factors as maternal age, inadequate nutrition, environmental 
pollutants and others are associated with decreased vascularization and/or blood flow in the 
placenta of several species (Redmer et al. 2004, Reynolds et al. 2006, 2013, Rennie et al. 
2011). Comparison of placental development at several stages of natural pregnancies with 
those achieved by various ART has shown differences in fetal size, placental and fetal 
growth, placental steroid metabolism, global DNA methylation, and expression of selected 
genes in several species (Barnes 2000, Cai et al. 2006, Grazul-Bilska et al. 2006, 2013, 
Allen et al. 2008, Collier et al. 2009, Delle Piane et al. 2010, Sellers Lopez et al. 2010, Esh-
Broder et al. 2011, Tomic & Tomic 2011, Ptak et al. 2013). In addition, placental vascular 
development is dramatically altered at term in pregnancies resulting from ART in sheep 
(Palmieri et al. 2007) and cattle (Hill et al. 2000, Miles et al. 2004, Miglino et al. 2007), and 
such alterations have been shown to occur as early as day 70 of pregnancy in cattle (Miles et 
al. 2005). Furthermore, reduced placental vascular development and increased vascular 
resistance during early pregnancy have been associated with early embryonic mortality 
(Meegdes et al. 1988; Bassil et al. 1995).
Beyond their immediate effects on pregnancy establishment, factors influencing placental 
vascular development have a dramatic impact on fetal growth and development, and 
therefore on birth weight as well as postnatal survival and growth (Reynolds & Redmer 
2001; Reynolds et al. 2010, 2013). Moreover, it has been shown that such postnatal effects 
impact not only the postnatal period but also life-long health and productivity in mammals, 
including humans and livestock (Nathanielsz 2006, Barker 2007, Vonnahme & Lemley 
2011, Reynolds & Caton 2012).
We hypothesized that placental vascularization and/or expression of factors involved in the 
regulation of angiogenesis would be altered very early (2–4 weeks after fertilization) in 
pregnancies achieved through transfer of embryos from various sources, including those 
from ART, compared with natural pregnancies. To test this hypothesis, we established 
pregnancies using a control group that was naturally mated (NAT), as well as three groups 
involving: (i) follicle stimulating hormone (FSH)-treatment to induce multiple follicle 
development (Stenbak et al. 2001, Grazul-Bilska et al. 2007) combined with natural mating, 
embryo flushing and embryo transfer (ET) to synchronized recipients (NAT-ET); (ii) 
transfer of embryos obtained through IVF of oocytes collected from FSH-treated ewes; and 
(iii) transfer of embryos obtained through in vitro activation (IVA; i.e., parthenotes – clones 
containing only maternal genes) of oocytes collected from FSH-treated donors, as described 
before (Grazul-Bilska et al. 2013). Therefore, the aim of this study was to determine 
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vascularization (e.g., vascular labeling index [LI] and the density of blood vessels) and the 
expression of mRNA for 14 factors involved in the regulation of angiogenesis in fetal and 
maternal placenta on day 22 of gestation in four pregnancy types: NAT, NAT-ET, IVF and 
IVA in sheep.
Materials and Methods
Animals and Tissue Collection
The North Dakota State University Institutional Animal Care and Use Committee approved 
all animal procedures used in this study. Animal use, experimental design and methodology 
are described in detail in a recently published paper (Grazul-Bilska et al. 2013). Tissue 
samples for this and previous (Grazul-Bilska et al. 2013) studies were collected from the 
same animals, but different measurements were performed. Briefly, estrus was synchronized 
using a CIDR device for 14 days (MWI, Boise, ID, USA) for adult ewes (n=67; Western 
Range ewes, primarily Rambouillet, Targhee and Columbia crossbred) randomly assigned to 
be naturally mated, or to serve as donors or recipients. Twenty four hours after CIDR 
removal, ewes (n=10) assigned to the NAT group were exposed to a fertile ram. For donor 
ewes in the NAT-ET, IVF and IVA groups, estrus was checked twice daily using a 
vasectomized ram. Donor ewes (n=3) for the NAT-ET group were treated twice daily with 
FSH-P (Sioux Biochemical, Sioux Center, IA, USA): on day 13 following estrus (day 0), 5 
mg/injection, day14, 4 mg/injection, and day15, 3 mg/injection as described before (Stenbak 
et al. 2001; Grazul-Bilska et al. 2006, 2012). Donor ewes (n=22) for the IVF and IVA 
groups were treated with FSH-P on days 13 and 14 after estrus, as described above. On Day 
15 of the estrous cycle, ewes from the NAT-ET group were exposed to a fertile ram for 48 h, 
but for the ewes in the IVF and IVA groups, ovaries were collected. Then, the oocytes were 
isolated, matured for 24 h, and fertilized or activated in vitro. To accomplish this, cumulus 
oocyte complexes (COC) were isolated from visible surface antral follicles >3 mm in 
diameter and incubated overnight in maturation medium (TCM199; Sigma, St. Louis, MO, 
USA; up to 30 COC/0.5 ml in a 4-well Nunc culture dish) supplemented with 10% fetal 
bovine serum (FBS, Sigma), ovine FSH [5 μg/mL; oFSH-RP-1; NIAMDD-NIH, Bethesda, 
MD, USA], ovine LH [5 μg/mL; oLH-26; NIADDK-NIH], estradiol −17β [1 μg/mL; 
Sigma], glutamine [2 mM; Sigma], sodium pyruvate [0.25 mM; Sigma], epidermal growth 
factor [10 ng/mL; Sigma,] and penicillin/streptomycin [100 units/mL penicillin and 100 
μg/mL streptomycin; Gibco, Grand Island, NY, USA]). After denuding oocytes of cumulus 
cells, half of the oocytes from each ewe were used for IVF and the other half for IVA.
For IVF, capacitated semen pooled from 5 Western range crossbreed rams frozen and stored 
in liquid nitrogen tank (−197 C) was thawed and viable sperm were separated in the 
modified sperm washing media (Irvine Scientific, Santa Ana, CA, USA) using the swim up 
technique (Grazul-Bilska et al. 2006, 2012). Oocytes were cultured in fertilization medium 
prepared in our laboratory consisting of synthetic oviductal fluid (SOF), 2% heat-inactivated 
ovine serum collected on day 0–1 of the estrous cycle and 1% penicillin/streptomycin in the 
presence of capacitated sperm (0.5 to 1 × 106 sperm/ml) for 24 h followed by incubation (at 
39°C, 5% O2, 5% CO2 and 90% N2) in culture medium until ET (Grazul-Bilska et al. 2003, 
2006, 2012, 2013). Culture medium consisted of SOF supplemented with bovine serum 
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albumin (BSA; 8 mg/ml; Sigma), glutamine (1 mM), MEM non-essential amino acids (0.01 
ml/ml, vol/vol; Sigma), BME amino acids (0.02 ml/ml, vol;/vol; Sigma) and penicillin/
streptomycin (100 units/mL penicillin and 100 μg/mL streptomycin). For IVA, oocytes were 
incubated for 5 min in TCM199 medium containing 2% FBS and ionomycin (2.5 μM; 
Sigma) followed by a 3-h incubation with 6-dimethylaminopurine (DMAP; 2 mM; Sigma). 
In vitro activated oocytes were then transferred to culture medium and incubated until ET 
(Grazul-Bilska et al. 2003, 2006, 2013).
For the NAT-ET group, on Day 5 post-mating (Day 1 = day of mating), embryos were 
flushed, evaluated using a stereomicroscope, and then transferred to synchronized recipients 
(3 embryos at morula stage from the same donor/recipient; n=9). For the IVF and IVA 
groups, in vitro-generated embryos at morula stage were transferred on Day 5 after 
fertilization or activation (Day 1 = day of fertilization or activation) to synchronized 
recipient ewes (3 embryos from the same donor/recipient; n= 10 and 13, respectively). On 
Day 22 after mating, fertilization or activation, fetuses and utero-placental tissues were 
collected from NAT, NAT-ET, IVF and IVA groups (n = 8, 7, 8, and 7 ewes, respectively). 
Pregnancy rates for NAT, NAT-ET, IVF and IVA groups were 80%, 78%, 80% and 54%, 
respectively.
Cross sections (approximately 0.5-cm thick) of the entire gravid uterus including fetal 
membranes (FM, chorioallantois) were fixed by immersion in formalin for Ki67 detection or 
Carnoy’s solution for smooth muscle cell actin (SMCA) detection, and then embedded in 
paraffin. For total cellular RNA extraction, FM (fetal placenta) and caruncular (CAR, 
maternal placenta) tissues were dissected from an area close to the embryo, snap-frozen in 
isopentane super-cooled in liquid nitrogen, and stored at −70 C. We chose Day 22 for tissue 
collection because in our previous experiments we demonstrated that between Days 20–22, 
major changes in cell proliferation, vascularization and expression of angiogenic factors 
occurred in fetal and maternal placenta in pregnancies achieved through natural mating 
(Grazul-Bilska et al. 2010, 2011). In addition, by Day 20 to 22 after mating placentation is 
already initiated in sheep (Igwebuike 2009).
Immunohistochemistry
Immunohistochemical procedures were performed as described by Grazul-Bilska et al. 
(2010, 2011, 2013). Briefly, paraffin-embedded uterine tissues containing FM were 
sectioned at 4 μm and mounted onto glass slides. Sections were rinsed several times in PBS 
containing Triton-X100 (0.3%, v/v) and then were treated for 20 min with blocking buffer 
[PBS containing normal horse serum (2%, vol/vol)] followed by overnight incubation at 4° 
C with specific primary antibody for Ki67 (a marker of proliferating cells; 1:500; mouse 
monoclonal; Vector Laboratories, Burlingame, CA, USA) or SMCA (a marker of pericytes 
and vascular smooth muscle cells and thus blood vessels; 1:150; mouse monoclonal; 
Oncogene Research Products; San Diego, CA, USA). Primary antibodies were detected 
using secondary anti-mouse antibody coupled to peroxidase (ImPress Kit; Vector 
Laboratories). For Ki67 staining, the sections were then counterstained with hematoxylin 
and periodic acid-Schiff’s reagent (H and PAS) to visualize cell nuclei as well as basement 
membranes and thus blood vessels (Reynolds & Redmer 1992). For SMCA staining, the 
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sections were counterstained with nuclear fast red (Sigma) to visualize cell nuclei. Control 
sections were incubated with normal mouse IgG (4 μg/mL) in place of primary antibody.
Image analysis
For each tissue section, images were taken at 600x (Ki67 staining) or 200x (SMCA staining) 
magnification using an Eclipse E600 Nikon microscope and digital camera (Nikon 
Instruments Inc., Melville, NY, USA) or Zeiss Imager M2 epifluorescence microscope 
equipped with Zeiss piezo automated stage and AxioCam HRm camera (Carl Zeiss 
International, Jena, Germany). Image analysis (Image-Pro Plus, Media Cybernetics, Inc., 
Bethesda, MD, USA) was performed for images of 5–10 randomly chosen fields of CAR to 
determine vascular cell proliferation based on Ki67 staining, while images of 5–40 randomly 
chosen fields from areas containing FM or CAR were used to determine the density of blood 
vessels based on SMCA staining, as described previously (Borowicz et al. 2007, Grazul-
Bilska et al. 2010, 2011, 2013). The LI was calculated as the percentage (%) of proliferating 
Ki67-positive cells out of the total number of cells within blood vessels which were marked 
with H and PAS/CAR tissue area.
Quantitative Real-Time RT-PCR
All procedures for determining the expression of mRNA of genes in ovine tissues by RT-
PCR along with sequences for 14 factors involved in the regulation of angiogenesis have 
been reported previously (Redmer et al. 2005; Grazul-Bilska et al. 2010, 2011). Briefly, 
snap-frozen CAR and FM tissues were homogenized in Tri-Reagent (Molecular Research 
Center; Cincinnati, OH, USA) and RNA was extracted according to the manufacturer’s 
specifications. The quality and quantity of total RNA were determined via capillary 
electrophoresis using the Agilent 2100 Bioanalyzer (Agilent Technologies, Wilmington, DE, 
USA). Real-time RT-PCR reagents, probes, and primers were purchased from and used as 
recommended by Applied Biosystems (Foster City, CA, USA). For each sample, 30 ng total 
RNA was reverse transcribed in triplicate 20-μl reactions using random hexamers. 
Sequence-specific Taqman probes and primers were designed using the Primer Express 
Software from Applied Biosystems. The ABI PRISM 7000 was used for detection of 
sequences amplified at 60°C typically for 40 or 45 cycles (Applied Biosystems). 
Quantification was determined from a relative standard curve of dilutions of the cDNA 
generated from tcRNA pooled from placentomes collected on day 130 of pregnancy. 
Expression of each gene was normalized to expression of 18S ribosomal RNA (rRNA) in a 
multiplex reaction using the human 18S pre-developed assay reagent (PDAR) from Applied 
Biosystems. The PDAR solution, which is primer limited and contains a VIC-labeled probe, 
was further adjusted using one-fourth the normal amount, so that it would not interfere with 
amplification of the FAM-labeled gene of interest. Standard curves were also generated with 
the multiplex solution, and the quantity of 18S rRNA and the gene of interest were 
determined using each specific standard curve. The concentrations of mRNA were then 
normalized to 18S rRNA by dividing each of the mRNA values by their corresponding 18S 
rRNA value.
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Data were analyzed using the general linear models (GLM) procedure of SAS (SAS Inst. 
2010) with the main effect of embryo origin (i.e., NAT, NAT-ET, IVF or IVA), and 
presented as means ± SEM. When the F-test was significant (P<0.05), differences between 
specific group means were evaluated using the least significant differences test (Kirk 1982). 
In addition, PROC CORR of SAS was used to calculate simple linear correlations between 
specific variables.
Results
In all pregnancy groups, Ki67 was detected in the nuclei of proliferating cells in blood 
vessels and other compartments of CAR (Fig. 1), and SMCA was detected in the blood 
vessels in FM and CAR (Fig. 2). Labeling index of vascular cells and the density of blood 
vessels in CAR and/or FM were affected by embryo origin. For CAR, the vascular LI was 
less (P<0.04) in the IVA group compared to any of the other groups, which were similar to 
each other (3.2±1.2 vs. 9.5±1.3%). In FM, the density of blood vessels was less (P<0.01) in 
IVA than in NAT or NAT-ET, and was intermediate in IVF (Fig. 3A). In CAR, the density 
of blood vessels was less (P<0.01) in NAT-ET, IVF and IVA than NAT (Fig. 3B). In NAT, 
the density of blood vessels was 39.1±3.5/106 μm2 and 39.4±4.3/106 μm2 in FM and CAR, 
respectively.
In all pregnancy types, in FM and CAR, mRNA were detected for the following: vascular 
endothelial growth factor (VEGF) and its receptors, FLT-1 and KDR; placental growth 
factor (PGF); neuropilin (NP) 1 and 2; the angiopoietins (ANGPT-1 and ANGPT-2) and 
their receptor, TEK; endothelial nitric oxide synthase (NOS3) and its receptor soluble 
guanylate kinase (GUCY1B3); hypoxia inducible factor-1A (HIF1A); and fibroblast growth 
factor (FGF) 2 and its receptor FGFR2 (Fig. 4).
Compared to NAT, mRNA expression in FM was less (P<0.01) for VEGF and FLT1 in 
NAT-ET, IVF and IVA, but KDR mRNA expression was similar for all groups (Fig. 4A).
Compared to NAT, VEGF mRNA expression in CAR was less (P<0.01) in NAT-ET and 
IVA, whereas IVF was intermediate (Fig. 4B). For FLT-1 mRNA in CAR, expression was 
less (P<0.01) in NAT-ET, IVF, and IVA, compared with NAT, but KDR mRNA expression 
was similar for all groups (Fig. 4B).
Compared to NAT, mRNA expression in FM was less for PGF (P<0.05) in NAT-ET and 
IVF, but was intermediate for IVA (Fig. 4C). Expression of mRNA in FM was less for NP1 
(P<0.08) in NAT-ET, IVF and IVA compared with NAT (Fig. 4C). In addition, in FM, 
mRNA expression for NP2 was greater in NAT-ET (P<0.02) than IVF and IVA, and NAT 
was intermediate (Fig. 4C).
Compared to NAT, PGF mRNA expression in CAR was less (P<0.01) in NAT-ET, IVF and 
IVA, but mRNA expression for NP1 and 2 was similar for all groups (Fig. 4D).
Compared to NAT, mRNA expression in FM was less (P<0.01) for ANGPT-1 in NAT-ET, 
IVF, and IVA (Fig. 4E). Expression of ANGPT2 mRNA in FM was less (P<0.05) in NAT-
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ET and IVA but not IVF (Fig. 4E). Expression of TEK mRNA was similar in FM of all 
groups (Fig. 4E).
Compared to NAT, mRNA expression in CAR was less (P<0.01) for ANGPT-1 in NAT-ET, 
IVF and IVA, but ANGPT-2 mRNA expression was similar for all groups (Fig. 4F). 
Compared to NAT, TEK mRNA expression in CAR was less (P<0.01) for IVF and IVA, but 
was intermediate in NAT-ET (Fig. 4F).
Compared to NAT, mRNA expression in FM was less (P<0.03) for NOS3 and HIF1A in 
NAT-ET and IVA, but in the IVF group was either intermediate (NOS3) or similar (HIF1A) 
to that of the NAT group (Fig. 4G). In FM, mRNA expression for GUCY1B3 was similar for 
all groups (Fig. 4G).
In CAR, mRNA expression of NOS3, GUCY1B3 and HIF1A (Fig. 4H) and for FGF2 and 
FGFR2 (Fig. 4J) was similar for all groups.
Compared to NAT, mRNA expression in FM was less (P<0.06) for FGF2 in NAT-ET, IVF 
and IVA, and for FGFR2 in FM was less (P<0.07) in NAT-ET and IVF but intermediate for 
IVA (Fig. 4I).
Supplementary Tables 1 and 2 present correlation coefficients for mRNA expression among 
factors involved in the regulation of angiogenesis and the density of blood vessels in FM and 
CAR, respectively. For FM, the VEGF system members were correlated with the ANGPT 
and FGF systems and with eNOS; there were 39 statistically significant correlations among 
these factors. In addition, for FM, ANGPT2 and eNOS were correlated with blood vessel 
density. For CAR, the VEGF system members were correlated with the ANGPT and FGF 
systems, and several factors (n=8) were correlated with the density of blood vessels. For 
CAR, there were 48 statistically significant correlations among these factors.
Discussion
The present study demonstrated that embryo origin and application of selected ART 
methods affect placental vascular development and mRNA expression of factors involved in 
the regulation of angiogenesis in fetal and placental tissues at a specific time point (Day 22) 
in early pregnancy. In fact, several measurements of vascularization/angiogenesis were 
decreased after transfer of embryos of different origin. Interestingly, altered blood flow, 
vascular development and/or expression of selected angiogenic and/or other growth factors 
have been demonstrated in the placenta of mid to late pregnancies compromised by factors 
causing fetal growth restrictions in several species (Reynolds et al. 2006, 2013, Vonnahme 
& Lemley 2011, Gourvas et al. 2012).
In the present study, decreased vascular cell proliferation in maternal placenta was observed 
only in the IVA group. This demonstrates that when embryos possess only maternal genes, 
cell proliferation in blood vessels of CAR appears to be altered. Thus, input of the paternal 
genome seems to be critical for blood vessel growth and development in the maternal 
placenta. Previously, we have demonstrated that the total cell proliferation in fetal and 
maternal placental tissues for the same pregnancy types was decreased in NAT-ET, IVF and 
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IVA groups compared to NAT (Grazul-Bilska et al. 2013). Thus, it seems that embryo 
origin has limited effects on placental blood vessel growth, but has more extensive effects 
on overall placental tissue growth at the early stages of pregnancy. Therefore, we 
hypothesize that the mechanisms of regulation of blood vessel cell proliferation differ from 
those involved in the regulation of proliferation of other cell types in the placenta.
A reduced density of blood vessels in FM or CAR was observed in NAT-ET, IVF or IVA 
groups in this study. This may be associated with reduced overall growth measured by cell 
proliferation in FM and CAR reported before for the same animal models (Grazul-Bilska et 
al. 2013). In addition, the IVA group had the lowest density of blood vessels in FM, and a 
very low vascular cell proliferation in CAR. These data indicate that in the absence of the 
paternal genome, fetal-maternal interactions are altered causing profoundly reduced 
vascularization in the maternal placenta.
Reduced vascular density in maternal and fetal placenta in pregnancies achieved after 
transfer of embryos created through IVF or oocyte activation reported in this study indicates 
that angiogenesis was impaired during early pregnancy. Therefore, application of ART may 
lead to inadequate placental vascularization and thus blood flow at least during early 
gestation, and eventually may contribute to compromised pregnancy.
Numerous factors are involved in the regulation of vascular function and growth in the 
placenta, including members of the VEGF, ANGPT, FGF, HIF families, and the NO system 
(Patan 2000, Reynolds & Redmer 1995, 2001; Zygmunt et al. 2003, Demir et al. 2007, 
Burton et al. 2009, Reynolds et al. 2010). Expression and function of these factors depend 
on stage of pregnancy, maternal age, and environmental and other factors (Reynolds et al. 
2010, 2013). In the present study, the mRNA expression of 12 out of 14 evaluated factors 
involved in the regulation of angiogenesis was decreased in FM and/or CAR in NAT-ET, 
IVF and/or IVA groups compared to the NAT control. Expression of mRNA for only two 
factors in placental tissues, KDR and GUCY1B3, remained unaffected by embryo origin in 
the present study.
Factors belonging to the VEGF family, including VEGF, FLT1 and PGF along with NP1 
and 2, which are involved in the VEGF and PGF signaling, and also members belonging to 
the ANGPT family are recognized as the major angiogenic factors in placental and other 
tissues (Ahmed & Perkins 2000, Reynolds & Redmer 2001, Neufeld et al. 2002, Wulff et al. 
2003, Reynolds et al. 2005, 2010, Chaballe et al. 2011, Koch et al. 2011). Expression of 
these factors has been demonstrated in maternal and/or fetal placenta from early to late 
pregnancy in sheep and other species (Reynolds & Redmer 2001, Borowicz et al. 2007, 
Grazul-Bilska et al. 2010, 2011, Reynolds et al. 2010, 2013). In our study, mRNA 
expression for several members of the VEGF family and NP1 or 2 was reduced in 
pregnancies achieved using ART. Furthermore, in compromised pregnancies such as those 
involving IUGR, pre-eclampsia or delivery of small-for-gestational age neonates, altered 
placental expression of members of the VEGF or ANGPT families, vascularization, plasma 
concentration of PGF and VEGF, or a balance between various angiogenic and/or 
antiangiogenic factors from mid to late stages have all been reported for humans and other 
species (Ahmed & Perkins, 2000, Regnault et al. 2002, Wulff et al. 2003, Redmer et al. 
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2005, 2009, Arroyo & Winn 2008, Erez et al. 2008). Thus, expression of members of the 
VEGF and ANGPT families are altered in specific pregnancy disorders at mid to late stages 
and early pregnancies achieved by transfer of embryos created through ART or oocyte 
activation. This indicates that changes in expression and possibly function of these factors 
may contribute to pregnancy disorders.
In FM, but not in CAR, expression of NOS3 and FGF2 mRNA, but not GUCY1B3 or FGFR2 
was affected by embryo origin in this study. Furthermore, expression of HIF1A mRNA in 
CAR but not FM was affected by embryo origin. Members of the NO and FGF systems, and 
HIF1A are expressed throughout pregnancy in the placenta of several species (Reynolds & 
Redmer, 2001; Kwon et al. 2004; Grazul-Bilska et al. 2010, 2011; Patel at al. 2010; 
Reynolds et al. 2010; Krause et al. 2011). It has been demonstrated that placental eNOS 
and/or HIF1A expression was reduced or altered in human preeclampsia at term (Rajakumar 
et al. 2007), and also in an ovine model of IUGR at mid to late stages (Galan et al. 2001, 
Ziebell et al. 2007). This indicates that expression and likely function of these factors are 
affected in compromised pregnancies, and therefore may contribute to abnormal placental 
and/or fetal development.
The NO system members interact with members of VEGF, ANGPT and FGF families, and 
they also play a regulatory role in placental angiogenesis, remodeling and 
immunosuppression (Purcell et al. 1999, Ahmed & Perkins 2000, Reynolds & Redmer 2001, 
Mata-Greenwood et al. 2008, Grazul-Bilska et al. 2010, 2011, Reynolds et al. 2010, Krause 
et al. 2011). The HIF1A and other members of the HIF family are involved in regulation of 
placental growth, remodeling, differentiation, transport and vascularization acting as key 
mediators of placental development and function and are therefore likely to be important 
contributors to both normal and adverse pregnancy outcomes (Pringle et al. 2010). Reduced 
expression of selected genes mentioned above may contribute to inadequate vascularization 
and blood flow to the fetus.
Reduced expression of several key factors regulating tissue growth and also vascular 
function in the placenta, including PGF, HIF1A, FGF2 and their receptors (Shimizu et al. 
2012) likely resulted in decreased placental cell proliferation and fetal size observed in our 
previous study using the same animal models (Grazul-Bilska et al. 2013). In addition, it has 
been recently demonstrated that expression of several imprinted genes (e.g., IGF2, H19 and 
PEG1) was less in FM in pregnancies achieved after ET of embryos created in vitro 
compared to natural early pregnancies (Ptak et al. 2013). This indicates that impaired tissue 
growth is associated with changes in expression of selected growth factors, as we observed 
in this study, and likely with imprinted genes.
Numerous factors involved in the regulation of angiogenesis interact with each other in 
order to control blood vessel function and development (Reynolds & Redmer 2001, 
Borowicz et al. 2007, Reynolds et al. 2010, 2013, Grazul-Bilska et al. 2010), which is 
reflected by significant correlations among these factors reported for FM and CAR in this 
study (supplementary Tables 1 and 2). Furthermore, correlations between 8 (out of 14) 
evaluated factors with the density of blood vessels in CAR observed in our study indicate 
functional associations between mRNA expression and blood vessel growth. The density of 
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blood vessels in FM was correlated with expression of 2 factors which indicates a different 
pattern of blood vessel growth and its regulation in fetal vs. maternal placenta.
In the present study, tissues were collected only at one stage of early pregnancy (Day 22) 
after transfer of embryos of different origin and application of selected ART including estrus 
synchronization using CIDR devices, FSH-treatment, IVF or IVA and ET. These procedures 
were associated with a decrease in expression of several genes involved in the regulation of 
angiogenesis in FM and/or CAR. Thus, selected ART methods, including estrus 
synchronization, superovulatory treatments and ET with or without IVF or IVA, which are 
used in animal production and human reproductive medicine, may have some negative 
effects on fetal and placental growth and function during pregnancy (Sinclair 2008, Laprise 
2009). In addition, it has been recently demonstrated that a specific estrus synchronization 
protocol may affect CAR vascular development during early pregnancy in sheep (Ruiz-
Gonzalez et al. 2013), and FSH-superovulatory treatment affected gene expression in bovine 
granulosa cells which may lead to altered function (Dias et al., 2013). Conversely, in several 
experiments in which we used a similar estrus synchronization and/or FSH treatment 
protocol as in this study, the rates of fertilization or blastocyst formation, and the 
development of fetuses or offspring in sheep seemed to be normal (Grazul-Bilska et al. 
2003, 2006, 2013). Although we and others observed changes in placental tissue growth, 
vascularization, expression of selected genes and global methylation after application of 
ART during early pregnancy (Grazul-Bilska et al. 2013, Ptak et al. 2013, Ruiz-Gonzalez et 
al. 2013), some compensatory mechanisms likely exist to minimize adverse effects of ART 
during early pregnancy and allow for normal fetal and placental growth and function 
throughout pregnancy and postnatal period. Alternatively, since pregnancies resulting from 
various ART, including IVF and SCNT, may exhibit poor placental development and 
vascularization as well as abnormal/altered fetal growth and development at different stages 
of gestation (Hoffert et al. 2005, Farin et al., 2006, Bauersachs et al. 2009, Collier et al., 
2009, Mansouri-Attia et al. 2009; Ptak et al. 2013), the effects observed during early 
pregnancy in the present study could have long-term consequences for pregnancy outcome. 
To determine long-term consequences of ART application, additional studies should be 
undertaken using offspring created through use of selected ART.
As we have discussed in our previous studies using different embryo origin and also ART 
(Grazul-Bilska et al. 2013), the embryo affects uterine function and has an active role in 
initiation of pregnancy, and in turn, the uterus affects fetal growth and development 
(Reynolds & Redmer 1995, 2001, Spencer et al. 2008, Barnea 2004, Ostrup et al. 2011, 
Grazul-Bilska et al. 2013). In fact, abnormal embryo/fetal-maternal communication, 
endometrial remodeling, reduced vascularization, altered expression of angiogenic factors 
and other problems during the peri-implantation and later pregnancy periods have been 
observed for pregnancies achieved after transfer of embryos created through somatic cell 
nuclear transfer (SCNT) in animal models (Hill et al. 2000, Loi et al. 2005, Miles et al. 
2004, 2005, Fletcher et al. 2007, Miglino et al. 2007, Palmieri et al. 2007, 2008, Campos et 
al. 2010). However, in pregnancies resulting from the transfer of embryos created through 
IVF, changes in endometrial vascularization, remodeling, and function were less pronounced 
than after transfer of embryos from SCNT (Hill et al. 2000, Miles et al. 2004, 2005, Miglino 
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et al. 2007, Palmieri et al. 2007, 2008, Mansouri-Attia et al. 2009, Hoffert et al. 2005). As 
we discussed before (Grazul-Bilska et al., 2013), endometrial tissues possess mechanisms to 
adapt to embryos of different origin, which may serve as a biological sensor to meet 
embryonic demands or adaptation to environmental conditions (Fleming et al. 2004, 
Borowicz & Reynolds 2010, Coan et al. 2010). This idea is in line with our hypothesis that 
during pregnancy some compensatory mechanisms may exist to reverse negative effects of 
embryo manipulations on placental and fetal growth.
In summary, in this study, transfer of embryos of different origins and application of ART 
decreased vascular cell proliferation in CAR, the density of blood vessels in FM and CAR, 
and expression of several factors involved in the regulation of placental angiogenesis on Day 
22 of pregnancy. Thus, embryo origin may have specific effects on vascular growth, and 
likely function, in the ovine placenta and fetus through regulation of tissue growth and 
angiogenesis, as well as other mechanisms such as epigenetic processes. Since relatively few 
studies have focused on evaluation of selected processes in the placenta during early 
gestation without or with application of ART in any species, these data provide novel 
information concerning fetal and placental vascular growth/cell proliferation and 
angiogenesis in relation to embryo origin. Furthermore, these data provide a foundation for 
determining the expression of specific factors regulating vascular development and function 
of placental and embryonic tissues in pregnancies after application of ART. In addition, 
these data will help us to better understand placental regulatory mechanisms in 
compromised pregnancies, and to identify strategies for rescuing such pregnancies.
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Representative photomicrographs of immunohistochemical detection of Ki67 (blackish 
nuclei, large arrows) followed by hematoxylin (bluish nuclei) and PAS (dark pink staining 
of basement membranes) staining in CAR from NAT (A), NAT-ET (B), IVF (C) and IVA 
(D) groups on Day 22 of pregnancy. Small arrows indicate examples of blood vessels, and 
large arrows point to examples of proliferating cells (Ki67-positive nuclei) within blood 
vessels. Bar on A (valid for B–C) = 50 μm. In inset in C/D, note the lack of positive Ki67 
staining in the control sections in which non-specific mouse IgG was used in place of the 
primary antibody.
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Representative photomicrographs of immunohistochemical detection of SMCA (blackish 
staining) followed by fast red (pinkish cell nuclei) staining in FM and endometrial (E) CAR 
from NAT (A), NAT-ET (B), IVF (C) and IVA (D) groups on Day 22 of pregnancy. Arrows 
indicate blood vessels in FM and stars in E of CAR in A–D. Bar = 50 μm for A–E. In E, 
note the lack of positive SMCA staining in the control sections in which non-specific mouse 
IgG was used in place of the primary antibody.
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The density of blood vessels (based on SMCA staining) in FM (A) and CAR (B) from NAT, 
NAT-ET, IVF and IVA groups on Day 22 of pregnancy. Data are expressed as a fold-change 
compared to the NAT group, which was arbitrarily set as 1. In NAT, the density of blood 
vessels was 39.1±3.5/106 μm2 and 39.4±4.3/106 μm2 in FM and CAR, respectively. Means 
± SEM with different superscript letters differ within tissue (a,bP < 0.01).
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Expression of mRNA for VEGF, FLT1, KDR (A and B), PGF, NP1, NP2 (C and D), 
ANGPT1, ANGPT2, TEK (E and F), NOS3, GUCY1B3, HIF1A (G and H), FGF2 and 
FGFR2 (I and J) in FM (left column; A, C, E, G and I) or CAR (right column; B, D, F, H 
and J) from NAT, NAT-ET, IVF and IVA groups on Day 22 of pregnancy. Data are 
expressed as fold change compared to NAT control arbitrarily set as 1. Means ± SEM with 
different superscript letters differ within a specific gene (a,b,c,d,e,fP < 0.01–0.08).
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